The exposome as a target for primary prevention and a tool for early detection of pancreatic cancer
Best Practice & Research Clinical Gastroenterology · 2025
DOI: 10.1016/j.bpg.2025.101991 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Best Practice & Research Clinical Gastroenterology, 2025. Verfasst von Gaetano Lauri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pancreatico-Biliary Endoscopy and Endosonography Division, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institu…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Early Detection of Cancer, Carcinoma, Pancreatic Ductal, Primary Prevention. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, AIRC, National Cancer Institute.
Abstract (Originalsprache)
Pancreatic Ductal Adenocarcinoma (PDAC) is a highly aggressive malignancy with limited survival due to late stage diagnosis and scarce therapeutic options. Emerging evidence highlights the role of the "exposome," which encompasses environmental, lifestyle, and metabolic exposures, as a crucial determinant in PDAC risk and a potential avenue for early detection. This review synthesizes findings on modifiable risk factors, including smoking, obesity, diabetes, diet, and alcohol consumption, and their interplay with genetic and metabolic profiles in PDAC development. Additionally, we explore cutting-edge approaches in exposomic research, such as biobanking, electronic health record analysis, and AI-driven predictive models, to identify early biomarkers and stratify high-risk populations. This integrated framework aims to inform prevention strategies and improve early detection of PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pancreatico-Biliary Endoscopy and Endosonography Division, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
- Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
- Pancreatico-Biliary Endoscopy and Endosonography Division, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. E…
Förderung
- NCI NIH HHS
- AIRC
- National Cancer Institute
- Associazione Italiana per la Ricerca sul Cancro
- European Union
Zitieren
APA
Lauri, G., Mills, K., Majumder, S., & Capurso, G. (2025). The exposome as a target for primary prevention and a tool for early detection of pancreatic cancer. Best Practice & Research Clinical Gastroenterology. https://doi.org/10.1016/j.bpg.2025.101991
Vancouver
Lauri G, Mills K, Majumder S, Capurso G. The exposome as a target for primary prevention and a tool for early detection of pancreatic cancer. Best Practice & Research Clinical Gastroenterology. 2025. doi:10.1016/j.bpg.2025.101991
BibTeX
@article{Lauri2025,
author = {Lauri, Gaetano and Mills, Krystal and Majumder, Shounak and Capurso, Gabriele},
title = {The exposome as a target for primary prevention and a tool for early detection of pancreatic cancer},
journal = {Best Practice & Research Clinical Gastroenterology},
year = {2025},
doi = {10.1016/j.bpg.2025.101991}
}
EUVIMED